These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 22644715)
1. Toward tailored medicine (and beyond): the phaeochromocytoma and paraganglioma model. Cuccurullo V; Mansi L Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1262-5. PubMed ID: 22644715 [No Abstract] [Full Text] [Related]
2. A comparison of the performance of ⁶⁸Ga-DOTATATE PET/CT and ¹²³I-MIBG SPECT in the diagnosis and follow-up of phaeochromocytoma and paraganglioma. Maurice JB; Troke R; Win Z; Ramachandran R; Al-Nahhas A; Naji M; Dhillo W; Meeran K; Goldstone AP; Martin NM; Todd JF; Palazzo F; Tan T Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1266-70. PubMed ID: 22526961 [TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of ⁶⁸Ga-DOTA-NOC PET-CT in phaeochromocytoma and paraganglioma: preliminary results from a single centre study. Naswa N; Sharma P; Nazar AH; Agarwal KK; Kumar R; Ammini AC; Malhotra A; Bal C Eur Radiol; 2012 Mar; 22(3):710-9. PubMed ID: 21971823 [TBL] [Abstract][Full Text] [Related]
10. Comparison of diagnostic value of I-123 MIBG and high-dose I-131 MIBG scintigraphy including incremental value of SPECT/CT over planar image in patients with malignant pheochromocytoma/paraganglioma and neuroblastoma. Fukuoka M; Taki J; Mochizuki T; Kinuya S Clin Nucl Med; 2011 Jan; 36(1):1-7. PubMed ID: 21157198 [TBL] [Abstract][Full Text] [Related]
11. EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma. Taïeb D; Timmers HJ; Hindié E; Guillet BA; Neumann HP; Walz MK; Opocher G; de Herder WW; Boedeker CC; de Krijger RR; Chiti A; Al-Nahhas A; Pacak K; Rubello D; Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1977-95. PubMed ID: 22926712 [TBL] [Abstract][Full Text] [Related]
12. Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations. Zelinka T; Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Reynolds JC; Ling A; Eisenhofer G; Lazúrová I; Adams KT; Whatley MA; Widimsky J; Pacak K Endocr Relat Cancer; 2008 Mar; 15(1):311-23. PubMed ID: 18310297 [TBL] [Abstract][Full Text] [Related]
13. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters. van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126 [TBL] [Abstract][Full Text] [Related]
14. Renaissance of (18)F-FDG positron emission tomography in the imaging of pheochromocytoma/paraganglioma. Taïeb D; Timmers HJ; Shulkin BL; Pacak K J Clin Endocrinol Metab; 2014 Jul; 99(7):2337-9. PubMed ID: 24878044 [No Abstract] [Full Text] [Related]
15. Single-photon emission computed tomography tracers in the diagnostics of neuroendocrine tumors. Pepe G; Bombardieri E; Lorenzoni A; Chiti A PET Clin; 2014 Jan; 9(1):11-26. PubMed ID: 25029930 [TBL] [Abstract][Full Text] [Related]
17. FDG PET in the evaluation of phaeochromocytoma: a correlative study with MIBG scintigraphy and Ki-67 proliferative index. Lin M; Wong V; Yap J; Jin R; Leong P; Campbell P Clin Imaging; 2013; 37(6):1084-8. PubMed ID: 24035263 [TBL] [Abstract][Full Text] [Related]
18. Role of [68Ga]DOTANOC PET/computed tomography and [131I]MIBG scintigraphy in the management of patients with pheochromocytoma and paraganglioma: a prospective study. Singh D; Shukla J; Walia R; Vatsa R; Paul N; Chhabra A; Nahar U; Singh H; Kumar R; Bhansali A; Rai Mittal B Nucl Med Commun; 2020 Oct; 41(10):1047-1059. PubMed ID: 32732602 [TBL] [Abstract][Full Text] [Related]
19. Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. Timmers HJ; Chen CC; Carrasquillo JA; Whatley M; Ling A; Havekes B; Eisenhofer G; Martiniova L; Adams KT; Pacak K J Clin Endocrinol Metab; 2009 Dec; 94(12):4757-67. PubMed ID: 19864450 [TBL] [Abstract][Full Text] [Related]
20. The evolution in the use of MIBG scintigraphy in pheochromocytomas and paragangliomas. Rufini V; Treglia G; Perotti G; Giordano A Hormones (Athens); 2013; 12(1):58-68. PubMed ID: 23624132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]